Recommended use of antiviralsPandemic (H1N1) 2009 briefing note 821 August 2009 | GENEVA - WHO is today issuing guidelines for the use of antivirals in the management of patients infected with the H1N1 pandemic virus.
The pandemic virus is currently susceptible to both of these drugs (known as neuraminidase inhibitors), but resistant to a second class of antivirals (the M2 inhibitors).
Healthy patients with uncomplicated illness need not be treated with antivirals.
At the same time, the presence of underlying medical conditions will not reliably predict all or even most cases of severe illness.
Antiviral use in childrenFollowing the recent publication of two clinical reviews, [1,2] some questions have been raised about the advisability of administering antivirals to children.